| Date | Acquired company | Acquiring company | Amount | Related |
|---|---|---|---|---|
| 2013-06-07 | Valneva's clinical manufacturing operations in Nantes (France) | Biological E (India) | undisclosed | manufacturing |
| 2013-06-04 | Isconova (Sweden) | Novavax (USA - MD) | $ 29.6 million (€ 22.6 million) | Vaccines |
| 2013-06-04 | Neurelis (USA) | Biotie Therapies (Finland) | up to $ 8.75 million | CNS diseases |
| 2013-05-29 | Okairos (Switzerland) | GSK (UK) | €250 million | Vaccines |
| 2013-05-28 | Omthera Pharmaceuticals (USA) | AstraZeneca (UK) | up to $443 million (€342.5 million) | |
| 2013-05-23 | Targeted Therapies division of Nordion (USA) | BTG plc (UK) | US$200 million (£133 million - €156.6 million) | Cancer - Oncology |
| 2013-05-22 | 48 % of Newbridge Pharmaceuticals (Dubai) | Elan (Ireland) | $40 million | Specialty pharmaceuticals |
| 2013-05-21 | Xellia Pharmaceuticals (Norway) | Novo A/S (Denmark) | $ 700 million (€ 543 million) | Infectious diseases |
| 2013-05-20 | AOP Orphan (Austria) | Elan (Ireland) | €263.5 million | Rare diseases |
| 2013-04-30 | Chrontech Pharma (Sweden) | group of shareholders | infectious diseases |
|
| 2013-04-29 | Ingenuity Systems (USA) | Qiagen (The Netherlands) | $105 million (€80.5 million) | Genomics |
| 2013-04-15 | Planet Biopharmaceuticals (USA) | Ares Life Sciences (Switzerland) | Allergy |
|
| 2013-04-12 | Genewave (France) Amplidiag (Finland) | Mobidiag (Finland) | undisclosed | Molecular diagnostic |
| 2013-04-03 | AlphaCore Pharma (USA) | MedImmune (USA - global biologics arm of AstraZeneca (UK) | undisclosed | Cardiovascular diseases |
| 2013-03-25 | SARcode Bioscience (USA) | Shire (UK-USA) | upfront payment of $160 million and additional significant undisclosed payments upon achievement of certain clinical, regulatory, and/or commercial milestones | Ophtalmological diseases |
| 2013-03-12 | Premacure (Sweden) | Shire (UK - USA) | undisclosed | Rare diseases |
| 2013-03-11 | EMF Consulting (France) | PhinC Development (France) | undisclosed | CRO |
| 2013-03-08 | Greer Laboratories (USA) | Ares Life Sciences (Switzerland) | undisclosed | allergy immunotherapy |
| 2013-03-01 | Encap Drug Delivery (UK) | Capsugel (USA) | undisclosed | drug services |
| 2013-02-28 | Genmab's non-plasma-derived antibody manufacturing facility (USA - Denmark) | Baxter (USA -IL) | $ 10 million (€ 7.6 million) | manufacturing |
